Novo Nordisk A/S (NVO)
49.07
+2.71
(+5.85%)
USD |
NYSE |
Dec 10, 16:00
49.00
-0.07
(-0.14%)
After-Hours: 16:02
Novo Nordisk Total Assets (Quarterly): 80.64B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Evaxion AS | 25.24M |
| Ascendis Pharma A/S | 1.357B |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Omeros Corp. | 185.71M |
| Viking Therapeutics, Inc. | 739.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.90B |
| Shareholders Equity (Quarterly) | 26.74B |
| Debt to Equity Ratio | 0.5957 |
| Current Ratio | 0.7761 |
| Net Debt Paydown Yield | -0.63% |